| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| REPLIGEN CORP | Director | Common Stock | 33.3K | $4.64M | $139.43 | May 15, 2025 | Direct |
| Neuronetics, Inc. | Director | Common Stock | 364K | $1.54M | $4.24 | May 22, 2025 | Direct |
| G1 Therapeutics, Inc. | Director | Common Stock | 0 | $0 | $2.51 | Sep 18, 2024 | Direct |
| REPLIGEN CORP | Director | Stock Option (Right to Buy) | 1.8K | May 15, 2025 | Direct | ||
| G1 Therapeutics, Inc. | Director | Stock Option (right to buy) | 0 | Sep 18, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| STIM | Neuronetics, Inc. | May 22, 2025 | 1 | $0 | 4 | May 27, 2025 | Director |
| RGEN | REPLIGEN CORP | May 15, 2025 | 2 | $0 | 4 | May 19, 2025 | Director |
| STIM | Neuronetics, Inc. | Feb 7, 2025 | 1 | $100K | 4 | Feb 10, 2025 | Director |
| RGEN | REPLIGEN CORP | Nov 19, 2024 | 2 | $690K | 4 | Nov 20, 2024 | Director |
| GTHX | G1 Therapeutics, Inc. | Sep 18, 2024 | 6 | $0 | 4 | Sep 18, 2024 | Director |
| STIM | Neuronetics, Inc. | Sep 5, 2024 | 1 | $20K | 4 | Sep 6, 2024 | Director |
| STIM | Neuronetics, Inc. | Aug 28, 2024 | 2 | $21.3K | 4 | Aug 30, 2024 | Director |
| STIM | Neuronetics, Inc. | Aug 20, 2024 | 1 | $25K | 4 | Aug 21, 2024 | Director |
| STIM | Neuronetics, Inc. | Aug 14, 2024 | 1 | $18.9K | 4 | Aug 16, 2024 | Director |
| RGEN | REPLIGEN CORP | Aug 1, 2024 | 2 | $181K | 4 | Aug 1, 2024 | Director |
| GTHX | G1 Therapeutics, Inc. | Jun 13, 2024 | 2 | $0 | 4 | Jun 14, 2024 | Director |
| STIM | Neuronetics, Inc. | May 30, 2024 | 1 | $0 | 4 | Jun 5, 2024 | Director |
| RGEN | REPLIGEN CORP | May 16, 2024 | 2 | $0 | 4 | May 20, 2024 | Director |
| GTHX | G1 Therapeutics, Inc. | Jun 15, 2023 | 2 | $0 | 4 | Jun 16, 2023 | Director |
| STIM | Neuronetics, Inc. | May 25, 2023 | 1 | $0 | 4 | May 30, 2023 | Director |
| RGEN | REPLIGEN CORP | May 18, 2023 | 2 | $0 | 4 | May 22, 2023 | Director |
| GTHX | G1 Therapeutics, Inc. | Jun 23, 2022 | 2 | $0 | 4 | Jun 24, 2022 | Director |
| RGEN | REPLIGEN CORP | May 26, 2022 | 2 | $0 | 4 | May 31, 2022 | Director |
| STIM | Neuronetics, Inc. | May 26, 2022 | 1 | $0 | 4 | May 31, 2022 | Director |
| GTHX | G1 Therapeutics, Inc. | Jun 17, 2021 | 2 | $0 | 4 | Jun 21, 2021 | Director |
| STIM | Neuronetics, Inc. | May 27, 2021 | 1 | $0 | 4 | Jun 1, 2021 | Director |
| RGEN | REPLIGEN CORP | May 13, 2021 | 2 | $0 | 4 | May 17, 2021 | Director |